Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VCYT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VCYT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Veracyte Inc

VCYT
Current price
27.08 USD +0.16 USD (+0.59%)
Last closed 26.58 USD
ISIN US92337F1075
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 2 154 434 560 USD
Yield for 12 month +25.89 %
1Y
3Y
5Y
10Y
15Y
VCYT
21.11.2021 - 28.11.2021

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

40.89 USD

P/E Ratio

65.50

Dividend Yield

Financials VCYT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VCYT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+445 764 000 USD

Last Year

+361 051 000 USD

Current Quarter

+114 473 000 USD

Last Quarter

+118 632 000 USD

Current Year

+298 145 000 USD

Last Year

+248 148 000 USD

Current Quarter

+79 508 000 USD

Last Quarter

+78 754 000 USD
EBITDA 62 280 000 USD
Operating Margin TTM 7.03 %
Price to Earnings 65.50
Return On Assets TTM 1.94 %
PEG Ratio
Return On Equity TTM 2.86 %
Wall Street Target Price 40.89 USD
Revenue TTM 463 392 992 USD
Book Value 15.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 18.20 %
Dividend Yield
Gross Profit TTM 326 407 008 USD
Earnings per share 0.42 USD
Diluted Eps TTM 0.42 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin 7.13 %

Stock Valuation VCYT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 65.50
Forward PE 20.70
Enterprise Value Revenue 4.15
Price Sales TTM 4.65
Enterprise Value EBITDA 35.73
Price Book MRQ 1.81

Technical Indicators VCYT

For 52 Weeks

19.73 USD 47.32 USD
50 Day MA 28.39 USD
Shares Short Prior Month 5 469 491
200 Day MA 34.81 USD
Short Ratio 6.04
Shares Short 5 942 060
Short Percent 8.47 %